FDA classifies opioid monitoring devices as medium-risk equipment
/ 1 min read
The Food and Drug Administration has officially classified a specific type of medical monitor used to track oxygen levels in patients at risk from opioids. The agency placed these devices into Class II, which is the category for moderate-risk medical equipment that requires special controls to ensure safety.
Why it matters: This action reduces the regulatory hurdle for manufacturers of opioid monitoring equipment. It allows companies to bring these devices to market faster using a simpler notification process rather than a full premarket approval. This could increase patient access to technology designed to prevent overdoses in clinical settings or at home, though it does not guarantee that any specific product is now available or approved for sale.
This information comes from a final order published by the Food and Drug Administration in the Federal Register; you should check the original document for full regulatory text before relying on it.
Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document